Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
220 participants
OBSERVATIONAL
2008-09-30
2009-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A
Subject's adherence to prescribed therapy will be monitored with an electronic compliance device.
MEMS cap
The Medication Event Monitoring System will be used to assess the level of subject adherence to recommended topical eye drop therapy.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MEMS cap
The Medication Event Monitoring System will be used to assess the level of subject adherence to recommended topical eye drop therapy.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* currently taking 1 or more hypotensive topical eye drops takes drops in the right eye for more than 6 months expect to continue drop use for the next 3 months
* subjects instill their own eye drops
* subject is able to take HVF tests
* subject will expect to complete the 3 months enrollment period
Exclusion Criteria
* eye drops are discontinued
* unable to take HVF test
* unable to complete follow-up
* investigators discontinue subject for safety reasons
* not using drops in left eye
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alcon Research
INDUSTRY
Robin, Alan L., M.D.
INDIV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Glaucoma Specialists
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jennifer L Stone, OD
Role: PRINCIPAL_INVESTIGATOR
Glaucoma Experts
Alan L Robin, MD
Role: PRINCIPAL_INVESTIGATOR
Glaucoma Specialists
Colleen K Protzko
Role: STUDY_DIRECTOR
Glaucoma Specialists
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Glaucoma Specialists
Baltimore, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Colleen K Protzko
Role: primary
Millie Brummett
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SI-08-54
Identifier Type: -
Identifier Source: org_study_id